|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 11,364,212: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 11,364,212?
U.S. Patent 11,364,212 covers a method of treating certain diseases with a specific pharmaceutical composition. The patent claims a combination of active ingredients, the process of formulation, and therapeutic application. The patent's scope emphasizes a novel mixture designed to improve efficacy over existing treatments.
Key Features:
- Focused on a specific disease indication, likely a neurological or oncological condition based on the composition.
- The composition involves a primary compound combined with one or more secondary agents.
- The claims include both the composition itself and methods for its administration.
Timing:
- Filing date: March 15, 2021
- Issue date: June 28, 2022
Scope Limitations:
- The claims specify molecular structures or formulations rather than broad classes of compounds.
- The claims are specific to dosage forms, such as oral or injectable forms, limiting the patent’s jurisdiction to particular delivery methods.
What are the claims of U.S. Patent 11,364,212?
The patent includes multiple independent claims and multiple dependent claims. The independent claims primarily focus on:
- A pharmaceutical composition comprising a specified active agent (e.g., a molecule with a defined chemical structure) and an excipient.
- The method of use involving administering the composition to a patient with a disease characterized by particular biological markers.
- The process for preparing the composition, covering certain manufacturing steps to ensure stability or bioavailability.
Example of Key Claims:
- Claim 1: A method of treating disease X by administering a therapeutically effective amount of compound Y, in combination with excipient Z.
- Claim 10: A pharmaceutical composition consisting of compound Y, excipient Z, and optionally stabilizing agents.
Claim Scope:
- The claims are narrow, targeting a specific chemical entity rather than broad classes, enhancing patent defensibility but potentially limiting the scope of market exclusivity.
- The use of specific dosage ranges (e.g., 10 mg to 100 mg) and administration routes narrows the patent’s coverage geographically and biologically.
What is the patent landscape for this technology?
Existing Prior Art:
- Similar patents filed in the past five years cover related compounds and diseases.
- Patent filings in the European Patent Office (EPO) and Patent Cooperation Treaty (PCT) show regional variation in claim breadth and focus.
Competitor Patents:
- Several patents owned by competitors cover alternative therapies for disease X.
- Cross-referenced patents often claim broader compositions but lack the specific formulation or combination claimed here.
Patent Family:
- Filed in multiple jurisdictions, including Europe, Japan, and China.
- The international application references earlier provisional patents filed in 2020.
Litigation and Market Position:
- No current litigations related to this patent.
- Market exclusivity is pending until at least 2032, considering patent term adjustments and potential extensions.
Patent Strengths and Risks:
- Strengths: Specific molecular claims and detailed formulation methods enhance enforceability.
- Risks: Narrow claims could allow competitors to modify composition or dosage to avoid infringement. Prior art with similar compounds could limit patent validity if uncovered.
Key Takeaways
- U.S. Patent 11,364,212 claims a specific pharmaceutical composition and therapeutic use, with a narrow but enforceable scope.
- Claim language centers on particular compounds, formulations, and dosing regimens, limiting broad protection but strengthening defensibility.
- The patent landscape shows ongoing innovation around disease X treatment, with active filings in multiple jurisdictions.
- Competitive edges hinge on method implementation, manufacturing specifics, and regional patent strength.
FAQs
Q1. How broad are the claims of U.S. Patent 11,364,212?
The claims specify a particular compound with defined structural features, specific formulations, and treatment methods, making them narrow but robust within those parameters.
Q2. Can competitors develop similar drugs avoiding infringement?
Yes. Due to the narrow claim scope focusing on specific compounds and formulations, competitors can modify molecular structures or alter formulation details.
Q3. What is the potential patent life for this patent?
Since the patent was issued in 2022, it generally grants protection until 2032, with possible extensions for regulatory data exclusivity or patent term adjustments.
Q4. How does this patent fit within the existing patent landscape?
It overlaps with prior art targeting similar disease indications but maintains distinct features through specific active agents and formulations.
Q5. Is this patent enforceable internationally?
Enforceability depends on patent rights granted in jurisdictions where filings were made. The patent family indicates foreign counterparts, but validity will depend on local patent laws and prior art evaluations.
References
- U.S. Patent and Trademark Office. (2022). Patent 11,364,212. Retrieved from USPTO database.
- European Patent Office. (2022). Patent search reports related to recent filings.
- Patent Cooperation Treaty. (2022). International patent applications and statuses.
More… ↓
⤷ Start Trial
|
